• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内质网应激通过体内和体外 PPARα 和 FoxO6 的相互作用诱导肝脂肪变性。

Endoplasmic reticulum stress induces hepatic steatosis through interaction between PPARα and FoxO6 in vivo and in vitro.

机构信息

Department of Food Science & Technology, College of Natural Resources and Life Science, Pusan National University, Miryang-Si, Gyeongsangnam-Do, 50463, Republic of Korea.

出版信息

J Mol Med (Berl). 2024 Oct;102(10):1267-1284. doi: 10.1007/s00109-024-02480-2. Epub 2024 Aug 28.

DOI:10.1007/s00109-024-02480-2
PMID:39198274
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11416408/
Abstract

Endoplasmic reticulum (ER) stress is a major cause of hepatic steatosis through increasing de novo lipogenesis. Forkhead box O6 (FoxO6) is a transcription factor mediating insulin signaling to glucose and lipid metabolism. Therefore, dysregulated FoxO6 is involved in hepatic lipogenesis. This study elucidated the role of FoxO6 in ER stress-induced hepatic steatosis in vivo and in vitro. Hepatic ER stress responses and β-oxidation were monitored in mice overexpressed with constitutively active FoxO6 allele and FoxO6-null mice. For the in vitro study, liver cells overexpressing constitutively active FoxO6 and FoxO6-siRNA were treated with high glucose, and lipid metabolism alterations were measured. ER stress-induced FoxO6 activation suppressed hepatic β-oxidation in vivo. The expression and transcriptional activity of peroxisome proliferator-activated receptor α (PPARα) were significantly decreased in the constitutively active FoxO6 allele. Otherwise, inhibiting β-oxidation genes were reduced in the FoxO6-siRNA and FoxO6-KO mice. Our data showed that the FoxO6-induced hepatic lipid accumulation was negatively regulated by insulin signaling. High glucose treatment as a hyperglycemia condition caused the expression of ER stress-inducible genes, which was deteriorated by FoxO6 activation in liver cells. However, high glucose-mediated ER stress suppressed β-oxidation gene expression through interactions between PPARα and FoxO6 corresponding to findings in the in vivo study-lipid catabolism is also regulated by FoxO6. Furthermore, insulin resistance suppressed b-oxidation through the interaction between FoxO6 and PPARα promotes hepatic steatosis, which, due to hyperglycemia-induced ER stress, impairs insulin signaling. KEY MESSAGES: Our original aims were to delineate the interrelation between the regulation of PPARα and the transcription factor FoxO6 pathway in relation to lipid metabolism at molecular levels. Evidence on high glucose promoted FoxO6 activation induced lipid accumulation in liver cells. The effect of PPARα activation of the insulin signaling. FoxO6 plays a pivotal role in hepatic lipid accumulation through inactivation of PPARα in FoxO6-overexpression mice.

摘要

内质网(ER)应激通过增加从头脂肪生成导致肝脂肪变性。叉头框 O6(FoxO6)是一种转录因子,介导胰岛素信号转导至葡萄糖和脂质代谢。因此,失调的 FoxO6 参与肝脂肪生成。本研究阐明了 FoxO6 在体内和体外 ER 应激诱导的肝脂肪变性中的作用。在过表达组成型激活 FoxO6 等位基因的小鼠和 FoxO6 敲除小鼠中监测肝 ER 应激反应和β-氧化。对于体外研究,用高葡萄糖处理过表达组成型激活 FoxO6 和 FoxO6-siRNA 的肝细胞,并测量脂质代谢改变。ER 应激诱导的 FoxO6 激活抑制体内肝β-氧化。组成型激活 FoxO6 等位基因显著降低过氧化物酶体增殖物激活受体 α(PPARα)的表达和转录活性。相反,FoxO6-siRNA 和 FoxO6-KO 小鼠中抑制β-氧化基因的表达减少。我们的数据表明,FoxO6 诱导的肝脂质积累受胰岛素信号的负调控。高葡萄糖处理作为高血糖状态导致 ER 应激诱导基因的表达,而在肝细胞中 FoxO6 激活则恶化了这种情况。然而,高葡萄糖介导的 ER 应激通过 PPARα 和 FoxO6 之间的相互作用抑制β-氧化基因表达,这与体内研究的结果一致——脂质分解代谢也受 FoxO6 调节。此外,胰岛素抵抗通过 FoxO6 和 PPARα 之间的相互作用抑制 b-氧化促进肝脂肪变性,这由于高血糖诱导的 ER 应激,损害了胰岛素信号。关键信息:我们最初的目的是在分子水平上阐明 PPARα 和转录因子 FoxO6 通路的调节之间的相互关系与脂质代谢有关。高葡萄糖促进 FoxO6 激活诱导肝脂肪变性的证据。胰岛素信号转导中 PPARα 激活的作用。FoxO6 在 FoxO6 过表达小鼠中通过失活 PPARα 发挥关键作用,导致肝脂质积累。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c71/11416408/6a697cb95133/109_2024_2480_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c71/11416408/a87e73451264/109_2024_2480_Fig1a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c71/11416408/d41087dc1193/109_2024_2480_Fig2a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c71/11416408/48e2073988f5/109_2024_2480_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c71/11416408/07baa5238c30/109_2024_2480_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c71/11416408/c1952af4c1b8/109_2024_2480_Fig5a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c71/11416408/547c1acc5bab/109_2024_2480_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c71/11416408/6a697cb95133/109_2024_2480_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c71/11416408/a87e73451264/109_2024_2480_Fig1a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c71/11416408/d41087dc1193/109_2024_2480_Fig2a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c71/11416408/48e2073988f5/109_2024_2480_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c71/11416408/07baa5238c30/109_2024_2480_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c71/11416408/c1952af4c1b8/109_2024_2480_Fig5a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c71/11416408/547c1acc5bab/109_2024_2480_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c71/11416408/6a697cb95133/109_2024_2480_Fig7_HTML.jpg

相似文献

1
Endoplasmic reticulum stress induces hepatic steatosis through interaction between PPARα and FoxO6 in vivo and in vitro.内质网应激通过体内和体外 PPARα 和 FoxO6 的相互作用诱导肝脂肪变性。
J Mol Med (Berl). 2024 Oct;102(10):1267-1284. doi: 10.1007/s00109-024-02480-2. Epub 2024 Aug 28.
2
Interaction between CHOP and FoxO6 promotes hepatic lipid accumulation.CHOP 与 FoxO6 相互作用促进肝脏脂质堆积。
Liver Int. 2020 Nov;40(11):2706-2718. doi: 10.1111/liv.14594. Epub 2020 Jul 26.
3
Activation of PPARα ameliorates hepatic insulin resistance and steatosis in high fructose-fed mice despite increased endoplasmic reticulum stress.过表达 PPARα 可改善高果糖喂养小鼠的肝胰岛素抵抗和脂肪变性,尽管内质网应激增加。
Diabetes. 2013 Jun;62(6):2095-105. doi: 10.2337/db12-1397. Epub 2013 Jan 24.
4
FoxO6-mediated ApoC3 upregulation promotes hepatic steatosis and hyperlipidemia in aged rats fed a high-fat diet.FoxO6 介导的 ApoC3 上调促进高脂饮食喂养的老年大鼠肝脂肪变性和血脂异常。
Aging (Albany NY). 2024 Mar 3;16(5):4095-4115. doi: 10.18632/aging.205610.
5
Hepatic mitochondrial and ER stress induced by defective PPARα signaling in the pathogenesis of hepatic steatosis.在肝脂肪变性发病机制中,由有缺陷的过氧化物酶体增殖物激活受体α(PPARα)信号传导诱导的肝脏线粒体和内质网应激。
Am J Physiol Endocrinol Metab. 2014 Jun 1;306(11):E1264-73. doi: 10.1152/ajpendo.00438.2013. Epub 2014 Apr 15.
6
Betaine Suppresses Lipid Accumulation in Liver: Inhibition of FoxO6 and PPARγ Interaction.甜菜碱抑制肝脏脂质积累:抑制FoxO6与PPARγ的相互作用。
J Med Food. 2024 Dec;27(12):1231-1242. doi: 10.1089/jmf.2024.k.0150. Epub 2024 Sep 12.
7
Sustained activation of PPARα by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice.内源性配体持续激活 PPARα 可增加肝脏脂肪酸氧化,预防 ob/ob 小鼠肥胖。
FASEB J. 2012 Feb;26(2):628-38. doi: 10.1096/fj.11-194019. Epub 2011 Oct 18.
8
Inhibition of mitochondrial β-oxidation by miR-107 promotes hepatic lipid accumulation and impairs glucose tolerance in vivo.miR-107对线粒体β-氧化的抑制作用会促进肝脏脂质积累并损害体内葡萄糖耐量。
Int J Obes (Lond). 2016 May;40(5):861-9. doi: 10.1038/ijo.2015.225. Epub 2015 Oct 26.
9
Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.过氧化物酶体增殖物激活受体-α激动剂 Wy 14,643 可改善非酒精性脂肪性肝炎糖尿病小鼠的代谢指标、脂肪变性和气球样变。
J Gastroenterol Hepatol. 2012 Feb;27(2):341-50. doi: 10.1111/j.1440-1746.2011.06939.x.
10
Nordihydroguaiaretic acid improves metabolic dysregulation and aberrant hepatic lipid metabolism in mice by both PPARα-dependent and -independent pathways.去甲二氢愈创木酸通过 PPARα 依赖和非依赖途径改善小鼠代谢失调和肝脏脂质代谢异常。
Am J Physiol Gastrointest Liver Physiol. 2013 Jan 1;304(1):G72-86. doi: 10.1152/ajpgi.00328.2012. Epub 2012 Oct 25.

本文引用的文献

1
Reply: A multi-society Delphi consensus statement on new fatty liver disease nomenclature.回复:关于新的脂肪性肝病命名的多学会德尔菲共识声明。
Hepatology. 2024 Mar 1;79(3):E93-E94. doi: 10.1097/HEP.0000000000000696. Epub 2023 Nov 20.
2
Altered FoxO1 and PPARγ interaction in age-related ER stress-induced hepatic steatosis.衰老相关内质网应激诱导肝脂肪变性中FoxO1与PPARγ相互作用的改变
Aging (Albany NY). 2019 Jun 25;11(12):4125-4144. doi: 10.18632/aging.102042.
3
Targeting endoplasmic reticulum stress in insulin resistance.靶向胰岛素抵抗中的内质网应激。
Trends Endocrinol Metab. 2015 Aug;26(8):438-48. doi: 10.1016/j.tem.2015.05.007. Epub 2015 Jun 12.
4
[Density equalizing mapping of obesity: analysis of a global epidemic].[肥胖症的密度均衡映射:全球流行趋势分析]
Z Gastroenterol. 2015 Jun;53(6):553-61. doi: 10.1055/s-0034-1398938. Epub 2015 Jun 15.
5
Forkhead Box O6 (FoxO6) Depletion Attenuates Hepatic Gluconeogenesis and Protects against Fat-induced Glucose Disorder in Mice.叉头框O6(FoxO6)缺失可减轻肝脏糖异生并预防小鼠脂肪诱导的葡萄糖紊乱。
J Biol Chem. 2015 Jun 19;290(25):15581-15594. doi: 10.1074/jbc.M115.650994. Epub 2015 May 5.
6
Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease.肥胖及其代谢并发症:脂肪因子的作用以及肥胖、炎症、胰岛素抵抗、血脂异常与非酒精性脂肪性肝病之间的关系。
Int J Mol Sci. 2014 Apr 11;15(4):6184-223. doi: 10.3390/ijms15046184.
7
A comprehensive review on metabolic syndrome.关于代谢综合征的综合综述。
Cardiol Res Pract. 2014;2014:943162. doi: 10.1155/2014/943162. Epub 2014 Mar 11.
8
FoxO6 integrates insulin signaling with MTP for regulating VLDL production in the liver.FoxO6 将胰岛素信号与 MTP 整合在一起,以调节肝脏中 VLDL 的产生。
Endocrinology. 2014 Apr;155(4):1255-67. doi: 10.1210/en.2013-1856. Epub 2014 Jan 17.
9
Prostacyclin and PPARα agonists control vascular smooth muscle cell apoptosis and phenotypic switch through distinct 14-3-3 isoforms.前列环素和过氧化物酶体增殖物激活受体 α 激动剂通过不同的 14-3-3 异构体控制血管平滑肌细胞凋亡和表型转换。
PLoS One. 2013 Jul 3;8(7):e69702. doi: 10.1371/journal.pone.0069702. Print 2013.
10
Liver diseases and aging: friends or foes?肝脏疾病与衰老:是敌是友?
Aging Cell. 2013 Dec;12(6):950-4. doi: 10.1111/acel.12128. Epub 2013 Jul 30.